-
细胞凋亡又称程序性细胞死亡,是生理性细胞死亡过程,对机体的发生、发展以及自身稳定起着关键性作用[1]。细胞的凋亡失控会导致细胞过早死亡,细胞不能正常的凋亡不仅会导致一系列的疾病,而且还会导致肿瘤细胞对化疗药物以及放疗的抵抗。凋亡蛋白抑制家族(inhibitor of apoptosis proteins,IAPs)的过表达以及第二个线粒体来源的Caspase激活因子(the second mitochondrial-derived activator of Caspase,Smac)的低表达与细胞凋亡失控及肿瘤的放疗抵抗密切相关[2]。因此,通过过表达促凋亡蛋白Smac或者应用其模拟物抑制IAPs有可能成为一种新的增加辐射敏感性的治疗方法。
Smac与肿瘤放射治疗
Effects of Smac on tumor radiotherapy
-
摘要: 放射治疗是肿瘤治疗的一个重要手段,肿瘤的辐射敏感性与凋亡蛋白抑制家族(IAPs)和促凋亡蛋白第二线粒体来源的Caspase激活因子(Smac)密切相关。IAPs能够通过结合Caspase-3、7、9抑制凋亡,IAPs的高表达是肿瘤细胞出现辐射抵抗的重要机制之一。当细胞接收到凋亡刺激信号后,Smac即从线粒体释放至胞质内与IAPs结合从而释放Caspase,发挥其促凋亡活性。以IAPs为靶点的治疗可能会为肿瘤细胞克服放射抵抗打开新的视角。临床前的体内体外研究证明,这种联合治疗值得更进一步的临床研究。使用IAPs拮抗剂联合放射治疗可能会为更有效的放射治疗肿瘤患者铺平道路。Abstract: Radiotherapy is one of the main methods of tumor therapy. The radiosensitivity of tumor is closely related to inhibitor of apoptosis proteins(IAPs)and the second mitochondria-derived activator of Caspase(Smac). IAPs can inhibit apoptosis by binding and inhibiting Caspase-3, 7, 9. High expression of IAPs has been shown to interfere with the efficacy of radiotherapy. Smac, upon apoptotic stimuli, is released into the cytoplasm to inhibit the caspase-binding activity of IAPs. Therapies targeting of IAP proteins may show new perspectives to overcome radioresistance. In vitro and in vivo preclinical studies have demonstrated that the combination approach warranted further clinical investigation. Thus, combination protocols using IAPs antagonists together with radiotherapy may pave the avenue to more effective radiation-based treatment options for tumor patients.
-
Key words:
- Apoptosis /
- Naoplasms /
- Smac /
- Caspase /
- Inhibitor of apoptosis proteins /
- Radiation tolerance
-
[1] Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell, 2011, 144(6):926-939. doi: 10.1016/j.cell.2011.03.002 [2] O'Brien MA, Kirby R. Apoptosis: A review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease[DB/OL]. WILEY: J Vet Emerg Crit Care, 2008[2013-03-14]. http://onli-nelibrary.wiley.com/doi/10.1111/j.1476-4431.2008.00363.x/full. [3] Greer RM, Peyton M, Larsen JE, et al. SMAC Mimetic(JP1201)sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Cancer Res, 2011, 71(24):7640-7648. doi: 10.1158/0008-5472.CAN-10-3947 [4] Olsson M, Zhivotovsky B. Caspases and cancer. Cell Death Differ, 2011, 18(9):1441-1449. doi: 10.1038/cdd.2011.30 [5] Hartman ML, Czyz M. Anti-apoptotic proteins on guard of melanoma cell survival. Cancer Lett, 2013, 331(1):24-34. doi: 10.1016/j.canlet.2013.01.010 [6] Qin S, Yang C, Li S, et al. Smac:Its role in apoptosis induction and use in lung cancer diagnosis and treatment. Cancer Lett, 2012, 318(1):9-13. doi: 10.1016/j.canlet.2011.12.024 [7] Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 2000, 102(1):33-42. doi: 10.1016/S0092-8674(00)00008-8 [8] Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 2000, 102(1):43-53. doi: 10.1016/S0092-8674(00)00009-X [9] Huang Y, Park YC, Rich RL, et al. Structural basis of caspase inhibition by XIAP:differential roles of the linker versus the BIR domain. Cell, 2001, 104(5):781-790. [10] Riedl SJ, Renatus M, Schwarzenbacher R, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell, 2001, 104(5):791-800. doi: 10.1016/S0092-8674(01)00274-4 [11] Bao ST, Gui SQ, Lin MS. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 2006, 5(4):580-583. [12] Kempkensteffen C, Jäger T, Bub J, et al. The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours. Int J Androl, 2007, 30(5):476-483. doi: 10.1111/j.1365-2605.2006.00742.x [13] Kempkensteffen C, Hinz S, Christoph F, et al. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value. J Cancer Res Clin Oncol, 2008, 134(5):543-550. doi: 10.1007/s00432-007-0317-7 [14] Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, et al. Role of Smac/DIABLO in cancer progression. J Exper Clin Cancer Res, 2008, 27(1):48. doi: 10.1186/1756-9966-27-48 [15] Pluta P, Cebula-Obrzut B, Ehemann V, et al. Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients. Neoplasma, 2011, 58(5):430-435. doi: 10.4149/neo_2011_05_430 [16] Sekimura A, Konishi A, Mizuno K, et al. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. Oncol Rep, 2004, 11(4):797-802. [17] 陈晓, 杨春鹿, 赵君, 等.非小细胞肺癌组织Livin和Smac蛋白表达及其临床意义的研究.中华肿瘤防治杂志, 2008(12):144-149.
[18] Dai CH, Li J, Shi SB, et al. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Jpn J Clin Oncol, 2010, 40(4):327-335. [19] 杨莉晖, 单春光, 黄红梅, 等. Smac和survivin在鼻腔鼻窦内翻性乳头状瘤中的表达.临床耳鼻咽喉头颈外科杂志, 2013, 27(8):407-410.
[20] McNeish IA, Bell S, McKay T, et al. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exper Cell Res, 2003, 286(2):186-198. doi: 10.1016/S0014-4827(03)00073-9 [21] Giagkousiklidis S, Vogler M, Westhoff MA, et, al. Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res, 2005, 65(22):10502-10513. doi: 10.1158/0008-5472.CAN-05-0866 [22] Fandy TE, Shankar S, Srivastava RK. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer, 2008, 7(1):60. [23] Chen DJ, Huerta S. Smac mimetics as new cancer therapeutics. Anticancer Drugs, 2009, 20(8):646-658. doi: 10.1097/CAD.0b013e32832ced78 [24] Berger R, Jennewein C, Marschall V, et al. NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosis. Mol Cancer Ther, 2011, 10(10):1867-1875. doi: 10.1158/1535-7163.MCT-11-0218 [25] Li W, Li B, Giacalone NJ, et al. BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro. J Thoracic Oncol, 2011, 6(11):1801-1809. doi: 10.1097/JTO.0b013e318226b4a6 [26] Ziegler DS, Keating J, Kesari S, et al. A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo. Neuro Oncology, 2011, 13(8):820-829. doi: 10.1093/neuonc/nor066 [27] Yang D, Zhao Y, Li A Y, et al. Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis. Breast Cancer Res Treat, 2012, 133(1):189-199. doi: 10.1007/s10549-011-1752-3 [28] Zhang S, Li G, Zhao Y, et al. Smac mimetic SM-164 potentiates APO2L/TRAIL-and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells[J/OL]. San Francisco: PLoS One, 2012[2013-03-14]. http://www.ncbi.nlm.nih.gov/pubmed/23240027. [29] Dai Y, Liu M, Tang W, et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin Cancer Res, 2008, 14(23):7701-7710. doi: 10.1158/1078-0432.CCR-08-0188 [30] Huerta S, Gao X, Livingston EH, et al. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201. Surgery, 2010, 148(2):346-353. [31] Chen F, Xu C, Du L, et al. Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis. Int J Oncol, 2013, 42(3):985. doi: 10.3892/ijo.2013.1785
计量
- 文章访问数: 2602
- HTML全文浏览量: 1450
- PDF下载量: 3